Society for Immunotherapy of Cancer (SITC) leaders have prioritized the following areas of focus in addressing regulatory issues relating to the field of cancer immunotherapy:
SITC has forged strategic relationships with government and regulatory entities from around the world to address key regulatory issues including formal liaison relationships with the U.S. Food and Drug Administration (FDA) and the National Cancer Institute/National Institutes of Health (NCI/NIH).
If you have partnership or policy-related questions, please contact SITC staff at SITCExecOffice@sitcancer.org.
Click here to view a complete listing of these institutions.
There is an urgent need among practicing oncologists and nurses for treatment algorithms that guide management of immunotherapy-related toxicities. Similarly, standardized templates for reporting adverse events in clinical trials are needed in order to facilitate monitoring and reporting of toxicities, an effort which is considered a high priority by the U.S. Food and Drug Administration.
To this end, SITC took the lead to convene a one-day Toxicity Management Workshop on Friday, March 31, 2017, in Washington, D.C. Click here to learn more about this event.
We have a patient with multiple brain metastases from melanoma beginning to develop symptoms (mental slowing and right facial droop) as we try to get him precerted for checkpoint inhibitor therapy. Any thoughts/anecdotes/data about how much if any ...
Did you know there are more than 800 resources available to SITC members? Access by your user type ( researcher , clinician , patient ) or by using the SITC Cancer Immunotherapy CONNECT Search (top right) to find exactly what you're looking ...
In light of what can occur in the TME in the steady state, malignant cells killed by intrinsic/extrincic stress factors in it can lead to danger-associated molecular patterns (e.g. HMGB-1) and plasma membrane exposure of the endoplasmic reticulum (ER) ...
Thank you everyone.Very helpful. ------------------------------ Jane Gutkovich Director of Research The EHE Foundation Woodbridge VA ------------------------------
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com